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A new synthetic methodology for cationic glycolipids using p-
aminophenyl-α-d-mannopyranoside (PAPM), p-aminophenyl-α-d-
galactopyranoside (PAPG) was developed. PAPM-lipids and PAPG-
lipids conjugates were also synthesized for targeting drugs to
receptors. A binding inhibition study of synthesized p-(dimethy-
lamino butylamido) phenyl-α-d-mannopyranoside (1a) with Con-
canavalin A was performed using invertase enzyme. In addition,
transfection of pSV-β-gal reporter gene with was investigated in
A549 cells.
& 2015 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations table
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featuresFig. 1. Lipid conCompounds 1a, 2a, 3a, and 1b, 2b, and 3b were synthesized starting from p-nitrophenyl-α-d-
mannopyranoside and p-nitrophenyl-α-d-galactopyranoside, respectively. All these compounds
were characterized by NMR, IR and Mass spectroscopy, optical rotation etc. Compound 1a was taken
as a representative sample for binding-inhibition studies and transfection.Data source location NA
Data accessibility The data is included in this article.Value of the data The article describes the synthesis of new lipid-carbohydrate conjugates.
 The synthesized compounds can be potentially used to target mannose cell surface receptors.
 The synthesized compounds 1a and 1b can potentially be used in transfection.jugates of p-aminophenyl-α-d-galactopyranoside and p-aminophenyl-α-d-mannopyranoside.
Fig. 2. Reagents: (a) Ac2O, Pyridine, rt (b) Amm. Formate, Pd-C, MeOH, EtOAc (c) (CH3)2N(CH2)3CO2H, DCC, DMAP, CH2Cl2
(d) NaOMe/MeOH.
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1.1. Synthesis and characterization
The schemes for synthesis of carbohydrate-lipid conjugates) are depicted in Figs. 1–5. All the
intermediates and ﬁnal products were characterized by 1H NMR, 13C NMR, IR, HRMS, and optical
rotation.1.2. Binding inhibition study
Concanavalin A (Con A), Invertase, and α-MM were purchased from Sigma Aldrich. Solutions of
compound 1a (2.5 mM,1.25 mM, 0.625 mM), α-MM (2.5 mM,1.25 mM, 0.625 mM), Con A (20 mM) and
Invertase (2 mM) were prepared in phosphate buffered saline (PBS pH 7.4). Solutions of 1a and α-MM,
at various concentrations were mixed with equal volumes of Con A or PBS in triplicate in microtiter
plate. Equal volumes of Invertase were added to each well resulting in the ﬁnal concentration of 1a
and α-MM 0.833 mM, 0.416 mM, and 0.208 mM. The ﬁnal concentration of Con A, and Invertase in test
wells were 6.6 mM and 0.66 mM, respectively. An increase in turbidity at 320 nm (OD320) was
monitored at room temperature using SpectraMax M2e (Molecular Devices, CA, USA) (Figs. 6 and 7).
Binding of Con A to Invertase was used as control (100%) aggregation and PBS was used a blank.
Fig. 3. Reagents: (a) Ac2O, Pyridine, rt (b) Amm. Formate, Pd-C, MeOH, EtOAc (c) (CH3)2N(CH2)3CO2H, DCC, DMAP, CH2Cl2
(d) NaOMe/MeOH.
Fig. 4. Reagents: (a) Myristic Acid, EDC, DMAP, CH2Cl2, (b) NaOMe/MeOH.
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Fig. 5. Reagents: (a) Cholesterol Chloroformate, Et3N, CH2Cl2, (b) NaOMe/MeOH.
Fig. 6. Inhibition of Invertase and Con A aggregation by 1a and α-MM after incubation at 24.5 1C for 7 min. The inhibition was
monitored at OD 320 nm.
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A549 cells (human lung cancer) were obtained from the National Cancer Institute (Frederick, MD)
and maintained in Dulbecco’s modiﬁed Eagle’s medium (DMEM) supplemented with 10% heat-
inactivated fetal bovine serum (FBS). DMEM, FBS and other cell culture reagents were purchased from
Life Technologies (Carlsbad, CA).
Log-phase A549 cells were seeded in 96-well plates (20,000 cells/well) and cultured overnight in a
standard 5% CO2 incubator. The culture medium was removed and cells were washed with sterile
Fig. 7. The kinetics of precipitation reaction between Invertase and Con A in the presence of varying amount of α-MM or
compound 1a. (A) α-MM (0.833 mM), Con A and Invertase, (B) α-MM (0.416 mM), Con A and invertase, (C) α-MM (0.208 mM),
Con A and invertase, (D) compound 1a (0.833 mM), con A and invertase, (E) compound 1a (0.416 mM), Con A and invertase,
(F) compound 1a (0.208 mM), Con A and invertase. The ﬁnal concentration of Con A and invertase in each test sample were
6.6 lM and 0.66 lM, respectively.
Fig. 8. Transfection of pSV-β-gal control vector gene with compound 1a in A549 cells. Cells were seeded in 96-well plate 24 h
before transfection. Cells were incubated with DNA-compound 1amixture of different charge ratios for 6 h. The total amount of
reporter gene was 0.2 lg/well.
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prepared by adding reporter gene, pSV-β-gal control vector (Promega, Madison, WI) into equal volume
of different concentrations of (1a) to yield a series of mixtures with þ/‐ charge ratios of 2:1; 4:1; 8:1;
16:1. The mixture was added to and incubated with the cells for 6 h before replaced with regular
culture medium. The cells were cultured for a total of 24 h. The total amount of DNA plasmid was
0.2 mg/well in 96-well plates. Both DNA plasmid and 1a were diluted with OptiMEM I medium (Life
Technologies (Carlsbad, CA). The transfection efﬁciency was determined using β-Galactosidase
Enzyme Assay System (Promega, Madison, WI) according to the manufacturer’s protocol (Fig. 8).
